| |
|
|
Sam Sung Pharm.Ind. (001360) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
6,800 | 5,370 | 5,440 | 4,590 |
| Yearly Lowest Price |
3,340 | 3,435 | 3,025 | 3,220 |
| Common Shares O/S |
5,589,733 | 7,589,733 | 7,589,733 | 7,589,733 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
276 | 354 | 269 | 246 |
| Dividends (%) |
- | - | - | - |
|
 |
(Company/Sector/Market) |
| |
2006.12 | 2007.12 |
| Beta |
0.85 / 0.92 / 1.00 | 0.58 / 0.75 / 1.00 |
| Volatility |
42.49 / 24.64 / 18.09 | 38.06 / 24.30 / 22.80 |
|
 |
(unit : Won) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Earnings Per Share |
- 1,693 | - 2,056 | - 312 | 148 |
| Sales Per Share |
4,943 | 4,894 | 4,345 | 4,007 |
| Book Value Per Share |
4,297 | 2,892 | 2,585 | 2,622 |
| Cash Flow Per Share |
101.72 | - 221.48 | - 197.72 | - 422.39 |
|
 |
(Unit : Times) |
| Fiscal Year End |
05.12 | 06.12 | 07.12 | 08.03 |
| Price / Earnings (H/L) |
-/- | -/- | -/- | 31.01/21.76 |
| Price / Sales (H/L) |
1.38/0.68 | 1.10/0.70 | 1.25/0.70 | 1.15/0.80 |
| Price / Book (H/L) |
1.58/0.78 | 1.86/1.19 | 2.10/1.17 | 1.75/1.23 |
| Price / Cash Flow (H/L) |
66.85 / 32.84 | - /- | - /- | - /- |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
04.12 |
05.12 |
06.12 |
07.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
617 |
501 |
597 |
480 |
611 |
524 |
621 |
544 |
| NOPLAT |
5 |
38 |
2 |
36 |
- 32 |
35 |
10 |
47 |
| Return on Invested Capital |
0 |
9 |
0 |
9 |
- 5 |
7 |
1 |
9 |
| WACC |
6 |
5 |
7 |
6 |
7 |
7 |
7 |
6 |
| Economic Value Added |
- 34.6 |
10.6 |
- 40.7 |
7.3 |
- 81.0 |
3.9 |
- 33.9 |
11.8 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2005.12 | 2006.12 | 2007.12 | 2008.03 |
| Enterprise Value(EV) |
454.00 | 458.44 | 401.44 | 386.74 |
| EBITDA |
- 38.73 | - 93.79 | 6.97 | 32.02 |
| EBITDA/Sales |
- 0.14 | - 0.33 | 0.02 | 0.11 |
| EBITDA/Financial Exp. |
- 2.67 | - 5.72 | 0.43 | 2.01 |
| EV/EBITDA |
- | - | 57.60 | 12.08 |
|
|
|
|
